- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Diabetes Mellitus - Type 2
Total 105098 results
-
University of Alabama at BirminghamCompletedType 2 Diabetes MellitusUnited States
-
Imperial College LondonAstraZeneca; Huma; North West London Collaboration of CCGs (NWL CCGs); Imperial...CompletedType 2 Diabetes MellitusUnited Kingdom
-
Universiti Sains MalaysiaCompleted
-
University of Alabama at BirminghamUnited States Department of Defense; Loma Linda University; Brenda Davis Nutrition... and other collaboratorsCompletedType 2 Diabetes Mellitus
-
Nanjing First Hospital, Nanjing Medical UniversityActive, not recruitingType 2 Diabetes MellitusChina
-
Centre Hospitalier Sud FrancilienCompleted
-
University of OsloNorwegian Diabetes AssociationCompleted
-
University Hospital, CaenCompletedType 2 Diabetes Mellitus
-
SanofiCompleted
-
SanofiCompletedType 2 Diabetes MellitusChina
-
SanofiCompletedType 2 Diabetes MellitusEstonia, Italy, Israel, United States, Canada, Germany, Romania, Slovakia, Spain
-
Universidad de GuanajuatoCompleted
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Japan, India, Puerto Rico, Mexico
-
Rush University Medical CenterWithdrawn
-
TheracosCompletedType2 Diabetes MellitusUnited States, Japan
-
Merck Sharp & Dohme LLCCompleted
-
Hospital de Clinicas de Porto AlegreCompletedType 2 Diabetes MellitusBrazil
-
Yonsei UniversityCompletedType2 Diabetes MellitusKorea, Republic of
-
Population Health Research InstituteHamilton Health Sciences CorporationCompletedType 2 Diabetes MellitusCanada
-
University of PretoriaSouth African Sugar AssociationCompletedType 2 Diabetes MellitusSouth Africa
-
AstraZenecaCompletedType 2 Diabetes MellitusKorea, Republic of
-
University of AlbertaCompleted
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusGermany, United States
-
Novo Nordisk A/SCompletedDiabetes | Type 2 Diabetes MellitusTaiwan, Turkey, India, Algeria, Hong Kong, China, Ukraine
-
Rutgers, The State University of New JerseyCompleted
-
University of OxfordNIHR Collaboration for Leadership in Applied Health Research and Care (Oxford)CompletedType 2 Diabetes MellitusUnited Kingdom
-
Kun-Ho YoonTakedaCompletedType 2 Diabetes MellitusKorea, Republic of
-
Mitsubishi Tanabe Pharma CorporationCompletedType 2 Diabetes MellitusJapan
-
Mitsubishi Tanabe Pharma CorporationCompletedType 2 Diabetes MellitusJapan
-
Samsung Medical CenterNovartisCompletedType 2 Diabetes MellitusKorea, Republic of
-
KeyBioscience AGNordic Bioscience A/SCompletedType 2 Diabetes MellitusDenmark, Czechia, Poland, Moldova, Republic of, Romania, United Kingdom
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
Duke-NUS Graduate Medical SchoolSingHealth PolyclinicsCompletedType 2 Diabetes MellitusSingapore
-
AstraZeneca TurkeyOptimum Contract Research Organization, TurkeyCompletedType 2 Diabetes MellitusTurkey
-
University of PalermoAstraZeneca; University of CataniaUnknown
-
LG Life SciencesCompleted
-
Biocon LimitedCompletedType 2 Diabetes Mellitus
-
Sun Yat-sen UniversitySuspended
-
Cheng Qing-fengUnknownType 2 Diabetes Mellitus
-
Merete Bechmann ChristensenNovo Nordisk A/SUnknownType 2 Diabetes MellitusDenmark
-
Sun Yat-sen UniversityUnknownType 2 Diabetes MellitusChina
-
First Affiliated Hospital Xi'an Jiaotong UniversityUnknownType 2 Diabetes MellitusChina
-
Novartis PharmaceuticalsCompletedType-2 Diabetes MellitusHong Kong
-
Dong-A ST Co., Ltd.CompletedType 2 Diabetes MellitusKorea, Republic of
-
National University of SingaporeNational University Hospital, SingaporeUnknown